- Home
- VCYT vs CPRX Comparison
VCYT vs CPRX Comparison
Compare VCYT & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCYT
- CPRX
- Stock Information
- Founded
- VCYT 2006
- CPRX 2002
- Country
- VCYT United States
- CPRX United States
- Employees
- VCYT N/A
- CPRX N/A
- Industry
- VCYT Medical Specialities
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- VCYT Health Care
- CPRX Health Care
- Exchange
- VCYT Nasdaq
- CPRX Nasdaq
- Market Cap
- VCYT 2.4B
- CPRX 2.6B
- IPO Year
- VCYT 2013
- CPRX 2006
- Fundamental
- Price
- VCYT $31.83
- CPRX $20.02
- Analyst Decision
- VCYT Buy
- CPRX Strong Buy
- Analyst Count
- VCYT 9
- CPRX 5
- Target Price
- VCYT $39.89
- CPRX $33.20
- AVG Volume (30 Days)
- VCYT 921.3K
- CPRX 1.5M
- Earning Date
- VCYT 11-05-2025
- CPRX 11-05-2025
- Dividend Yield
- VCYT N/A
- CPRX N/A
- EPS Growth
- VCYT N/A
- CPRX 183.96
- EPS
- VCYT 0.34
- CPRX 1.65
- Revenue
- VCYT $479,129,000.00
- CPRX $558,499,000.00
- Revenue This Year
- VCYT $14.19
- CPRX $16.51
- Revenue Next Year
- VCYT $9.68
- CPRX $9.58
- P/E Ratio
- VCYT $95.21
- CPRX $12.10
- Revenue Growth
- VCYT 19.91
- CPRX 28.55
- 52 Week Low
- VCYT $22.61
- CPRX $19.15
- 52 Week High
- VCYT $47.32
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- VCYT 58.59
- CPRX 46.35
- Support Level
- VCYT $30.67
- CPRX $19.66
- Resistance Level
- VCYT $32.34
- CPRX $20.52
- Average True Range (ATR)
- VCYT 1.18
- CPRX 0.67
- MACD
- VCYT -0.06
- CPRX 0.03
- Stochastic Oscillator
- VCYT 73.71
- CPRX 42.08
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).